[1] 司新成,辛艳峰.心血管神经症诊断及治疗体会[J].中外医学研究,2015,13(20 ):130-131.
[2] 中华医学会心血管病分会介入心脏病学组,中国医师协会心血管内科医师分会,血栓防治专业委员会和中华心血管杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016). [J].中华心血管病杂志,2016,44(8):382-400.
[3] 王 薇,赵 冬,孙佳艺,等.中国11队列人群危险因素与不同类型心血管病发病危险的比较[J].中华心血管病杂志,2006,34(12):1133-1137.
[4] Li J, Luo Y, Xu Y ,et al. Risk factors of peripheral arterial disease and relationship between low ankle-brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes[J]. Circ J,2007,71(79):377-381.
[5] Yusuf S, Hawken S, Qunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial in 52 countries(the INTERHEART study):case-control study[J]. Lancet, 2004,364(9438):937-952.
[6] Global Burden of Metabolic Risk Factors for Chronic Disease Collaboration(BMI Mediated Effects),Lu Y, Hajifathalian K, et al. Metabolic mediators of Effects of body-mass index, overweight, and obesity on coronary heart disease and stroke :a pooled analysis of prospective cohorts with 1.8 million participants [J]. Lancet, 2014,383(9921):970-983.
[7] 郭艺芳. 心脏病学实践2014[M]. 北京:人民卫生出版社, 2014:5-7.
[8] 胡大一. 心脏病学实践2010[M]. 北京:人民卫生出版社2010:1-4.